Sarfaraz K. Niazi Ph.D. is the largest solo inventor of bioprocessing inventions with over 100 inventions (31), additionally including new drugs, new dosage forms, bioequivalence testing methods and a large number of other patient-related inventions that are widely used across the globe. His patented invention of demonstrating analytical similarity methods (32) was accepted by the FDA to allow waiver of patient trials of biosimilar products. We believe that there remains an unmet need to invent a process or a system that would allow aging to proceed extremely fast without modifying the natural process of aging that imparts a unique character to alcoholic beverages. Dr. Niazi’s extensive expertise allows us to introduce BioProcessing Techniques to accelerate the process without modifying the natural mechanism of aging. This will result in an alcoholic beverage that is far superior in its native character expected by connoisseurs without any variation in the quality of the product across batches.